The Effect of Switching to the High-Efficient Rosuvastatin on the Success of Lipid Lowering Therapy in High Risk Patients. The CORVUS (Controlled Targets for High Vascular Risk Patients Using Effective Statins) Study
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 292
◽
pp. 231-233
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 40
(9)
◽
pp. 1484-1495.e22
◽
Keyword(s):
2008 ◽
Vol 15
(6)
◽
pp. 314-323
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 3
(2)
◽
pp. 19-25
Keyword(s):